Findings suggest bispecific CD3xCD20 therapy may offer an option for patients with Richter syndrome who are ineligible for ...
MedPage Today on MSN
Revised MS Criteria Aim to Speed Diagnosis
The McDonald criteria revisions provide a unified approach for diagnosing MS from pediatric to late-life presentations, said ...
The FDA has approved the CytoCell KMT2A Breakapart FISH Probe Kit PDx as a companion diagnostic (CDx) to accompany revumenib (Revuforj), a first-in-class Menin inhibitor for the treatment of relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback